Megami Ophthalmology-B (06622.HK): The Australian Therapeutic Goods Administration has accepted the registration application for Atropine Sulfate eye drops (0.02% dosage).

Financial and Economic News App, the eye-care company Zhaoke Ophthalmology -B (06622.HK) announced that on June 2, 2026, the Australian Therapeutic Goods Administration has accepted the registration application from the company for its atropine sulfate eye drops (0.02% dose, product code: NVK002) used to slow down the progression of myopia in children.